Simplex Trading’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$238K Buy
36,718
+36,121
+6,050% +$250K ﹤0.01% 4087
2025
Q4
$4.7K Sell
597
-3,822
-86% -$24.6K ﹤0.01% 7471
2025
Q3
$22K Buy
4,419
+2,156
+95% +$11K ﹤0.01% 7261
2025
Q2
$13K Buy
2,263
+1,221
+117% +$6.46K ﹤0.01% 7121
2025
Q1
$6K Buy
+1,042
New +$7.19K ﹤0.01% 7475
2024
Q4
Sell
-83
Closed 9390
2024
Q3
$0 Sell
83
-40
-33% -$361 ﹤0.01% 9336
2024
Q2
$1K Buy
123
+36
+41% +$290 ﹤0.01% 8531
2024
Q1
$0 Buy
+87
New +$726 ﹤0.01% 9658
2023
Q3
Sell
-142
Closed -$1K 9581
2023
Q2
$1K Buy
+142
New +$1.76K ﹤0.01% 8697
2021
Q4
Sell
-217
Closed -$2.71K 11232
2021
Q3
$3K Hold
217
﹤0.01% 9449
2021
Q2
$3K Buy
217
+174
+405% +$3.24K ﹤0.01% 9636
2021
Q1
$0 Buy
+43
New +$1.03K ﹤0.01% 9785

Other funds holding PROF

Simplex Trading's PROF Position: Q1 2026 in Review

Simplex Trading increased its Profound Medical (PROF) stake by 6,050% in Q1 2026, buying an estimated $250K and bringing the position to 36,718 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #4087.

Simplex Trading first reported a position in PROF in Q1 2021 and has held it in 12 quarters since. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Simplex Trading held 36,718 shares of Profound Medical worth $238K as of Q1 2026.
  • Simplex Trading bought 36,121 Profound Medical shares in Q1 2026, an estimated $250K.
  • Profound Medical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4087 holding.
  • Simplex Trading first reported a position in Profound Medical in Q1 2021 and has held it in 12 quarters since.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.